高级搜索

赖氨酸甲基转移酶SET8结构和功能及其与肿瘤关系的研究进展

王静, 徐金升, 白亚玲, 张胜雷

王静, 徐金升, 白亚玲, 张胜雷. 赖氨酸甲基转移酶SET8结构和功能及其与肿瘤关系的研究进展[J]. 肿瘤防治研究, 2015, 42(04): 403-406. DOI: 10.3971/j.issn.1000-8578.2015.04.019
引用本文: 王静, 徐金升, 白亚玲, 张胜雷. 赖氨酸甲基转移酶SET8结构和功能及其与肿瘤关系的研究进展[J]. 肿瘤防治研究, 2015, 42(04): 403-406. DOI: 10.3971/j.issn.1000-8578.2015.04.019
WANG Jing, XU Jinsheng, BAI Yaling, ZHANG Shenglei. Association of Structure and Functions of Lysine Methyltransferase SET8 with Tumorigenesis[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 403-406. DOI: 10.3971/j.issn.1000-8578.2015.04.019
Citation: WANG Jing, XU Jinsheng, BAI Yaling, ZHANG Shenglei. Association of Structure and Functions of Lysine Methyltransferase SET8 with Tumorigenesis[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 403-406. DOI: 10.3971/j.issn.1000-8578.2015.04.019

赖氨酸甲基转移酶SET8结构和功能及其与肿瘤关系的研究进展

基金项目: 河北省自然科学基金(H2012206157)
详细信息
    作者简介:

    王静(1989-),女,硕士在读,主要从事肾脏肿瘤机制方面相关研究

    通讯作者:

    徐金升,E-mail: xjs5766@126.com

  • 中图分类号: R73-37

Association of Structure and Functions of Lysine Methyltransferase SET8 with Tumorigenesis

  • 摘要: SET8(又称SETD8、PR-SET7、KMT5a)是现今发现唯一能够特异性单甲基化H4K20的赖氨酸甲基转移酶。SET8及其催化形成的H4K20me1共同参与了细胞周期调控、染色质结构及基因转录的调节。近年来研究发现SET8在多种肿瘤组织中高表达,参与调控体内细胞的细胞周期、增殖及凋亡等过程,涉及肿瘤的发生、生长、转移等多个环节,有望成为肿瘤治疗的新靶点。本文主要从SET8的结构、功能及其在肿瘤发生中的作用等方面综述了SET8的研究进展。

     

    Abstract: SET8, also named SETD8, PR-SET7 or KMT5a, is a sole lysine methyltransferase that catalyzesmonomethylation of histone H4 lysine 20(H4K20). SET8 and the H4K20me1 catalyzed by SET8 are jointly implicated in modulating cell cycle, maintaining chromatin structure and regulating the transcription of several genes. Recently, it is reported that the high expression of SET8 involves in regulating cell cycle, cell proliferation and apoptosis. SET8 is also related with tumorigenesis, progression and metastasis, suggesting that SET8 may be a potential target for cancer treatment. In this review, we focus on analyzing the association of the structure and function of SET8 and its effect in tumorigenesis.

     

  • [1] Xiao B, Jing C, Kelly G, et al. Specificity and mechanism of the histone methyltransferase Pr-Set7[J]. Genes Dev, 2005, 19(12): 14 44-54.
    [2] Couture JF, Collazo E, Brunzelle JS, et al. Structural and functional analysis of SET8, a histone H4 Lys-20 methyltransferase[J]. Genes Dev, 2005, 19(12): 1455-65.
    [3] Fang J, Feng Q, Ketel CS, et al. Purification and functional characterization of SET8, a nucleosomal histone H4-lysine 20 -specific methyltransferase[J]. Curr Biol, 2002, 12(13): 1086-99.
    [4] Abbas T, Shibata E, Park J, et al. CRL4(Cdt2) regulates cell proliferation and histone gene expression by targeting PR-Set7/ Set8 for degradation[J]. Mol Cell, 2010, 40(1): 9-21.
    [5] Liang XQ, Du YP, Wang DL, et al. The biological functions of lysine methyltransferase PR-SET7[J]. Yi Chuan, 2013, 35(3): 24 1-54.
    [6] Wu S, Wang W, Kong X, et al. Dynamic regulation of the PRSet7 histone methyltransferase is required for normal cell cycle progression[J]. Genes Dev, 2010, 24(22): 2531-42.
    [7] Oda H, Okamoto I, Murphy N, et al. Monomethylation of histone H4-lysine 20 is involved in chromosome structure and stability and is essential for mouse development[J]. Mol Cell Biol, 2009, 29 (8): 2278-95.
    [8] Houston SI, McManus KJ, Adams MM, et al. Catalytic function of the PR-Set7 histone H4 lysine 20 monomethyltransferase is essential for mitotic entry and genomic stability[J]. J Biol Chem, 20 08, 283(28): 19478-88.
    [9] Wu S, Rice JC. A new regulator of the cell cycle: the PR-Set7 histone methyltransferase[J]. Cell Cycle, 2011, 10(1): 68-72.
    [10] Le e J , Zh o u P. SETt i n g t h e c l o c k f o r h i s t o n e H4 monomethylation[J]. Mol Cell, 2010, 40(3): 345-6.
    [11] Yin Y,Yu VC, Zhu G, et al. SET8 plays a role in controlling G1/S transition by blocking lysine acetylation in histone through binding to H4 N-terminal tail[J]. Cell Cycle, 2008, 7(10): 14 23-32.
    [12] Sakaguchi A, Steward R. Aberrant monomethylation of histone H4 lysine 20 activates the DNA damage checkpoint in Drosophila melanogaster[J]. J Cell Biol, 2007, 176(2): 155-62.
    [13] Davey CA, Sargent DF, Luger K, et al. Solvent mediated interactions in the structure of the nucleosome core particle at 1.9 a resolution[J]. J Mol Biol, 2002, 319(5): 1097-113.
    [14] Dorigo B, Schalch T, Bystricky K, et al. Chromatin ?ber folding: requirement for the histone H4 N-terminal tail[J]. J Mol Biol, 20 03, 327(1): 85-96.
    [15] Trojer P, Li G, Sims RJ 3rd, et al. L3MBTL1, a histonemethylation- dependent chromatin lock[J]. Cell, 2007, 129(5): 91 5-28.
    [16] Scharf AN, Meier K, Seitz V, et al. Monomethylation of lysine 20 on histone H4 facilitates chromatin maturation[J]. Mol Cell Biol, 20 09, 29(1): 57-67.
    [17] Lu X, Simon MD, Chodaparambil JV, et al. The effect of H3K79 dimethylation and H4K20 trimethylation on nucleosome and chromatin structure[J]. Nat Struct Mol Biol, 2008, 15(10): 1122-4.
    [18] Li Z, Nie F, Wang S, et al. Histone H4 Lys 20 monomethylation by histone methylase SET8 mediates Wnt target gene activation[J]. Proc Natl Acad Sci U S A, 2011, 108(8): 3116-23.
    [19] Yang F, Sun L, Li Q, et al. SET8 promotes epithelial-mesenchymal transition and confers TWIST dual transcriptional activities[J]. EMBO J, 2012, 31(1): 110-23.
    [20] Shi X, Kachirskaia I, Yamaguchi H, et al. Modulation of p53 function by SET8-mediated methylation at lysine 382[J]. Mol Cell, 2007, 27(4): 636-46.
    [21] Takawa M, Cho HS, Hayami S, et al. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression[J]. Cancer Res, 2012, 72(13): 3217-27.
    [22] Song F, Zheng H, Liu B, et al. An miR-502-binding site singlenucleotide polymorphism in the 3’-untranslated region of the SET8 gene is associated with early age of breast cancer onset[J]. Clin Cancer Res, 2009, 15(19): 6292-300.
    [23] Colaluca IN, Tosoni D, Nuciforo P, et al. NUMB controls p53 tumour suppressor activity[J]. Nature, 2008, 451(7174): 76-80.
    [24] Dhami GK, Liu H, Galka M, et al. Dynamic methylation of Numb by Set8 regulates its binding to p53 and apoptosis[J]. Mol Cell, 20 13, 50(4): 565-76.
    [25] Guo Z, Wu C, Wang X, et al. A polymorphism at the miR-502 binding site in the 3’-untranslated region of the histone methyltransferase SET8 is associated with hepatocellular carcinoma outcome[J]. Int J Cancer, 2012, 131(6): 1318-22.
    [26] Fabbri M, Croce CM, Calin GA. MicroRNAs[J]. Cancer J, 2008, 14 (1): 1-6.
    [27] Yang S, Guo H, Wei B, et al. Association of miR-502-binding site single nucleotide polymorphism in the 3’-untranslated region of SET8 and TP53 codon 72 polymorphism with non-small cell lung cancer in Chinese population[J]. Acta Biochim Biophys Sin(Shanghai), 2014, 46(2): 149-54.
    [28] Xu J, Yin Z, Gao W, et al. Genetic variation in a microRNA-502 minding site in SET8 gene confers clinical outcome of non-small cell lung cancer in a Chinese population[J]. PLoS One, 2013, 8( 10): e77024.
    [29] Ding C, Li R, Peng J, et al. A polymorphism at the miR-502 binding site in the 3’ untranslated region of the SET8 gene is associated with the outcome of small-cell lung cancer[J]. Exp Ther Med, 2012, 3(4): 689-92.
    [30] Wang C, Guo Z, Wu C, et al. A polymorphism at the miR-502 binding site in the 3’ untranslated region of the SET8 gene is associated with the risk of epithelial ovarian cancer[J]. Cancer Genet, 2012, 205(7-8): 373-6.
计量
  • 文章访问数:  1485
  • HTML全文浏览量:  296
  • PDF下载量:  681
  • 被引次数: 0
出版历程
  • 收稿日期:  2014-03-10
  • 修回日期:  2014-08-21
  • 刊出日期:  2015-04-24

目录

    /

    返回文章
    返回
    x 关闭 永久关闭